Applicant, as named in the Orange Book
Supernus Pharms
Next listed expiry: Oxtellar Xr on 13 Apr 2027. 4 products with live protection, 0 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Oxtellar Xr · 3 strengths oxcarbazepine | 13 Apr 2027 |
| Trokendi Xr · 4 strengths topiramate | 4 Apr 2028 |
| Qelbree · 3 strengths viloxazine hydrochloride | 2 Apr 2035 |
| Gocovri · 2 strengths amantadine hydrochloride | 23 Aug 2038 |
Recent events
- 25 Oct 2026Qelbree · Generic tentatively approved 28 Apr 2026
- 25 Oct 2026Qelbree · Generic tentatively approved 8 Oct 2026
- 24 Oct 2026Oxtellar Xr · Enters 12-month window basis: patent13 Apr 2027
- 24 Oct 2026Oxtellar Xr · Enters 12-month window basis: patent13 Apr 2027
- 24 Oct 2026Oxtellar Xr · Enters 12-month window basis: patent13 Apr 2027